News

The House of Representatives today voted 251-158 to pass legislation (H.R. 1309) that would require the Occupational Safety and Health Administration to issue a workplace violence prevention standard, and health care and social service employers to comply with the standard to participate in Medicare.

Sens. Maggie Hassan, D-N.H., and Susan Collins, R-Maine, yesterday introduced the Senate companion to the Opioid Workforce Act.

Next week marks the 20th anniversary of the landmark Institute of Medicine report “To Err Is Human: Building a Safer Health System.”

Cedars-Sinai President and CEO Tom Priselac talks with Diane Meier, M.D., director of the Center to Advance Palliative Care, about building a culture of goal-concordant care for seriously ill patients.

Nearly 1.7 million people selected a 2020 health plan through HealthCare.gov Nov. 1-16.

The Senate Health, Education, Labor and Pensions Committee today held a hearing on President’s Trump nomination of Stephen Hahn, M.D., to lead the Food and Drug Administration as commissioner.

Robyn Begley, AHA senior vice president and chief nursing officer for its American Organization for Nursing Leadership, and Priya Bathija, vice president of AHA’s The Value Initiative, participated today in a panel discussion sponsored by the National Academy of Medicine’s Committee on the Future of Nursing 2020-2030.

The National Center for Healthcare Leadership last night presented its 2019 Gail L. Warden Leadership Excellence Award to Rodney Hochman, M.D., president and CEO of Renton, Wash.,-based Providence St. Joseph Health and chair-elect designate of the AHA Board of Trustees.

The House of Representatives today voted 231-192 to approve a continuing resolution that would fund the federal government through Dec. 20 and delay impending Medicaid cuts, among other provisions.

The AHA and Federation of American Hospitals today urged Congress to oppose S. 2860 as well as any other legislation that would repeal current law limiting self-referral to physician-owned hospitals.

The National Quality Forum’s Measure Applications Partnership today released the annual list of performance measures under consideration for use in hospital and other Medicare public reporting and payment programs.

The Centers for Disease Control and Prevention today released updated guidance to help health care providers diagnose and treat patients with vaping-associated lung injury.

Addressing social needs, increasing access to medication-assisted treatment and naloxone, as well as better integrating substance use disorder treatment with physical care are crucial steps hospitals and health systems can and are taking to combat the opioid epidemic.

The Centers for Disease Control and Prevention today updated its Core Elements for Hospital Antibiotic Stewardship Programs to reflect experience and evidence since releasing the elements of successful stewardship programs in 2014.

The Food and Drug Administration Friday approved the first duodenoscope with a disposable elevator component, a part difficult to clean and reprocess.

Building upon and improving the current system in order to increase access to health coverage is a better way forward than a Medicare for All alternative, panelists said Nov. 17 at U.S. News & World Report's Healthcare of Tomorrow conference in Washington, D.C.

Preserving rural health and advancing health in America go hand-in-hand.

The Administration today released a final rule requiring hospitals to disclose payer-specific negotiated rates, along with a proposed rule that would impose new requirements on private insurers in the individual and group markets to publicly disclose negotiated rates and out-of-network allowed amounts, and give their enrollees real-time, personalized access to cost-sharing information.

The House Ways and Means Committee today requested input on priority topics for its Rural and Underserved Communities Health Task Force to consider as it works to improve care delivery and health outcomes in these communities.

The Food and Drug Administration yesterday approved an antibacterial drug to treat adults with complicated urinary tract infections.